Localized grey matter atrophy in multiple sclerosis: A meta-analysis of voxel-based morphometry studies and associations with functional disability

Grey matter (GM) damage in Multiple Sclerosis (MS) occurs largely independent of white matter (WM) lesions and shows stronger correlation with clinical parameters than WM damage but no clear pattern of GM atrophy distribution has emerged in the literature. We used Signed Differential Mapping (SDM),...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience and biobehavioral reviews Vol. 37; no. 5; pp. 819 - 830
Main Authors Lansley, J., Mataix-Cols, D., Grau, M., Radua, J., Sastre-Garriga, J.
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier 01.06.2013
Subjects
Online AccessGet full text
ISSN0149-7634
1873-7528
1873-7528
DOI10.1016/j.neubiorev.2013.03.006

Cover

More Information
Summary:Grey matter (GM) damage in Multiple Sclerosis (MS) occurs largely independent of white matter (WM) lesions and shows stronger correlation with clinical parameters than WM damage but no clear pattern of GM atrophy distribution has emerged in the literature. We used Signed Differential Mapping (SDM), a novel neuroimaging meta-analytical method, to assess global and regional GM volume differences in MS. Meta-regression methods were used to explore potential effects of disease duration and degree of functional disability. We found a highly localized pattern of regional GM volume loss in Relapsing Remitting MS involving bilateral thalamus, basal ganglia structures, pre/postcentral regions and cingulate gyrus. These results remained largely unchanged after subgroup and sensitivity analyses. Furthermore, GM volume loss in left pre/postcentral regions correlated with increasing functional disability in MS. These results demonstrate that GM atrophy occurs as a regional rather than global process in MS, and that functional disability is specifically associated with atrophy of the left pre/post central gyrus. Further investigation is needed to determine whether these structures are targeted by neurodegenerative processes and to establish their clinical and neurocognitive correlates.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0149-7634
1873-7528
1873-7528
DOI:10.1016/j.neubiorev.2013.03.006